Crime

Sessions

  • Plenary session
  • Poster session
  • Big debate
  • Structured session
  • Workshop
  • Oral presentation session
  • Short communication session
  • Poster guided tour

Crime, legislation and regulation

Comorbidity — Crime

Criminal justice/prisons — Crime
Wednesday, 23 October
13:20

Improving delivery of healthcare programmes

13:20 to 14:50
Central square 3 (C3)
Graça Vilar
16:50

Extending the evidence-base of opioid substitution treatment

16:50 to 18:20
Insights zone 4 (I4)
John Marsden
Friday, 25 October
09:00

Illicit drug markets: strategic analysis for a safer Europe

09:00 to 10:30
Insights zone 2 (I2)
Roumen Sedefov

Presentations

  • Plenary session
  • Poster session
  • Big debate
  • Structured session
  • Workshop
  • Oral presentation session
  • Short communication session
  • Poster guided tour

Wednesday, 23 October

13:30
Oral presentation

Balancing welfare and market institutional logics. Procurement regulations for social services, such as addiction treatment, in four Nordic welfare countries

13:30 to 13:45
Central square 3 (C3)
Kerstin Stenius
13:45
Oral presentation

Can liaison and diversion services increase referral to drug and alcohol treatment?

13:45 to 14:00
Central square 3 (C3)
Kate Morley
14:00
Oral presentation

Treatment in therapeutic communities: the experience of Lisbon and Tagus Valley Region

14:00 to 14:15
Central square 3 (C3)
Elizabete Pereira
14:15
Oral presentation

The influence of institutional response on the individual's recovery from drug misuse

14:15 to 14:30
Central square 3 (C3)
Carolina Cunha
17:00
Oral presentation

Predictors of treatment allocation guesses in a randomised controlled trial testing double-blind injectable hydromorphone and diacetylmorphine for severe opioid use disorder

17:00 to 17:15
Insights zone 4 (I4)
Kirsten Marchand
17:15
Oral presentation

Illicit stimulant use in the context of daily injectable opioid agonist treatment: a grounded theory study with patients receiving treatment for severe opioid use disorder in Vancouver, Canada

17:15 to 17:30
Insights zone 4 (I4)
Heather Palis
17:30
Oral presentation

The effect of entry and retention in opioid substitution therapy on contact with the criminal justice system among opioid dependent people

17:30 to 17:45
Insights zone 4 (I4)
Natasa Gisev
17:45
Oral presentation

Depot buprenorphine for opioid dependence in prisons in NSW, Australia

17:45 to 18:00
Insights zone 4 (I4)
Adrian Dunlop
18:00
Oral presentation

Slow release oral morphine versus methadone for the treatment of opioid use disorder: a systematic review and meta-analysis

18:00 to 18:15
Insights zone 4 (I4)
Jan Klimas

Friday, 25 October

09:10
Oral presentation

A framework for understanding the EU illicit drug market

09:10 to 09:25
Insights zone 2 (I2)
Nicola Singleton
09:25
Oral presentation

Ramifications of illicit drug markets: pilot data on drug-related homicide

09:25 to 09:40
Insights zone 2 (I2)
Teodora Groshkova
09:55
Oral presentation

The European markets for cannabis, heroin and cocaine

09:55 to 10:10
Insights zone 2 (I2)
Laurent Laniel
10:10
Oral presentation

The European markets for synthetic stimulants and new psychoactive substances

10:10 to 10:25
Insights zone 2 (I2)
Andrew Cunningham